Nikon Corporation has invested in biotechnology startup Setsuro Tech Inc. to enhance its existing technologies and create synergies in cell production biotechnology.
Information on the Target
Setsuro Tech Inc. is an innovative biotechnology startup founded on research from Tokushima University. Located in Tokushima, Japan, the company focuses on advancing research support services and precision breeding through its proprietary genome editing technologies. Led by CEO Shinichiro Takezawa, Setsuro Tech is dedicated to developing organisms with newly engineered traits, contributing to the evolution of biotechnological applications.
The company operates out of the Fujii Memorial Institute of Medical Sciences, leveraging its cutting-edge research capabilities to offer unique solutions in the biotechnology sector. With a strong emphasis on scientific advancements, Setsuro Tech aims to position itself as a leader in genomic innovation.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Japan
The biotechnology industry in Japan has seen substantial growth, driven by advancements in genetic engineering and cell production technologies. The Japanese government has actively promoted biotechnology through s
Similar Deals
HCRx → CSL Vifor and Maruishi Pharmaceutical Co., Ltd.
2023
Ricoh Lease Co., Ltd. → Feed Inc.
2023
Santen Pharmaceutical Co., Ltd. → Novagali Pharma S.A.
2023
JGC Holdings Corporation → Alpha Fusion
2023
JGC Holdings Corporation → TwoCells and MedRhythms Inc.
2021
Nikon Corporation
invested in
Setsuro Tech Inc.
in 2023
in a Corporate VC deal